A detailed history of Axq Capital, LP transactions in Incyte Corp stock. As of the latest transaction made, Axq Capital, LP holds 35,897 shares of INCY stock, worth $2.07 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
35,897
Previous 3,200 1021.78%
Holding current value
$2.07 Million
Previous $201 Million 917.8%
% of portfolio
0.49%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$56.55 - $66.59 $1.85 Million - $2.18 Million
32,697 Added 1021.78%
35,897 $2.05 Billion
Q4 2023

Feb 13, 2024

SELL
$52.16 - $64.19 $1 Million - $1.23 Million
-19,200 Reduced 85.71%
3,200 $201 Million
Q3 2023

Nov 14, 2023

BUY
$57.77 - $65.93 $1.29 Million - $1.48 Million
22,400 New
22,400 $1.29 Billion

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $12.8B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Axq Capital, LP Portfolio

Follow Axq Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axq Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Axq Capital, LP with notifications on news.